On 25 September 2026, an online masterclass was held featuring Viktor Oshovskyi, Doctor of Medical Sciences and a highest-category obstetrician-gynaecologist renowned for his expertise in foetal medicine.
During the event, the participants reviewed current clinical algorithms for assessing patients’ conditions and the principles of individualised management of gynaecological disorders. Key topics included the physiological balance of the vaginal microbiome, current approaches to the diagnosis and treatment of bacterial vaginosis, the limits of justified medical intervention, and updated recommendations concerning the role of sexual partners.
The expert placed particular emphasis on the vaginal microbiome as a fundamental component of the female body’s local defence mechanisms. He highlighted the role of lactobacilli, particularly Lactobacillus crispatus, in maintaining a healthy vaginal environment through lactic acid production. Changes in the composition of the vaginal microbiota may be associated with adverse health outcomes, particularly during pregnancy, making timely diagnosis and a well-considered clinical approach essential.
Bacterial vaginosis is one example of such an imbalance. It is characterised by a reduction in beneficial lactobacilli and an increase in the abundance of anaerobic microorganisms. The expert stressed that contemporary gynaecological and obstetric practice requires a clear understanding of the indications for intervention. While symptomatic bacterial vaginosis during pregnancy requires treatment as prescribed by a physician, routine screening of asymptomatic pregnant women solely to prevent preterm birth is not recommended.
Viktor Oshovskyi also devoted considerable attention to the management of sexual partners, noting that emerging research highlights an association between sexual activity and the risk of recurrent episodes of vaginal dysbiosis. Of particular interest to practising physicians was the discussion of recommendations from the American College of Obstetricians and Gynecologists (ACOG), updated in 2025. These recommendations address the possibility of concurrent treatment of a male sexual partner in certain cases of recurrent symptomatic bacterial vaginosis. However, the decision to adopt this approach should be made on an individual basis, with particular consideration given to the clinical circumstances during pregnancy.
The masterclass also explored key approaches to comprehensive support for women’s health. The speaker highlighted the importance of a rational approach to using products containing beneficial probiotic microorganisms to support the intestinal and vaginal microbiota.
Florium®-A was presented as an example of such a product. This food supplement contains five Lactobacillus strains, providing a total of 11 billion colony-forming units (CFU) per capsule: L. crispatus – 4 billion CFU, L. gasseri – 2 billion CFU, L. jensenii – 2 billion CFU, L. rhamnosus – 2 billion CFU, and L. acidophilus – 1 billion CFU.
The discussion also covered approaches to supporting the natural recovery of the vaginal mucosa. Specialists were introduced to Bifly, a product in the form of vaginal suppositories intended for hygienic and preventive use. Its combination of chlorhexidine bigluconate, provitamin B5 (dexpanthenol), and macrogols is designed to provide an antiseptic effect and support the condition of the vaginal mucosa. According to the product’s stated characteristics, its local action and compatibility with lactobacilli are important considerations in maintaining the vagina’s natural protective barrier.
In conclusion, the expert emphasised that a rational approach to women’s health should be based on evidence-based medicine, accurate differential diagnosis, individualised patient management, and adherence to current recommendations from leading professional organisations.
Florium®-A is a food supplement. It is not a medicinal product. Does not contain GMOs. It is recommended to consult your physician before use. The product should not be used as a substitute for a balanced diet. Bifly is a hygienic and preventive agent. It is not a medicinal product. Read the instructions before use. During pregnancy and breastfeeding, consult a physician regarding the advisability of use.